RxDoctor Payments Data

Mustafa Al-Mashat, MD

Critical Care Medicine · Cheverly, MDNPI 1821397290

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,310 of the $1,610 with a category attached, or 81.4%. 10 manufacturers reported payments, led by Abiomed at 25.9% of the total.

$1,610in general payments, 2019–2025

Across 16 payments — averaging $100.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$416
  • Bard Access Systems, Inc.$300
  • Getinge USA Sales, LLC$182
  • Inari Medical, Inc.$170
  • Abbott$129
  • Chiesi USA, Inc.$125
  • plus $287 from 4 others
$147in research payments, 2019–2025

Across 1 payment — averaging $147.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$147

What the payments were for

  • Consulting fees$30019%
  • Food & beverage$1,31081%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,610 in reported general payments places this provider in the 80th percentile of 231 critical care medicine providers in Maryland.

See all critical care medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$65,904
Medicare patients
109
Services billed
328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Cheverly

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →